Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5427]
News [12612]
Articles [172]
Editorials [5]
Conferences [246]
elearning [17]
Pembrolizumab is safe and effective and substantially increases overall...
Dr Edward B. Garon - UCLA, Los Angeles, USA
Pembrolizumab is safe and effective and substantially increases overall survival in aNSCLC patients ( Dr Edward B. Garon - UCLA, Los Angeles, USA )
1 Jun 2019
Comment: The use of CDK 4/6 inhibitors now translates to a significant survival...
Dr Harold Burstein - Dana-Farber Cancer Institute, Boston, USA
Comment: The use of CDK 4/6 inhibitors now translates to a significant survival benefit in breast cancer treatment ( Dr Harold Burstein - Dana-Farber Cancer Institute, Boston, USA )
1 Jun 2019
Ribociclib and endocrine therapy improves survival for pre-menopausal women...
Dr Sara A. Hurvitz - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA
Ribociclib and endocrine therapy improves survival for pre-menopausal women with advanced breast cancer ( Dr Sara A. Hurvitz - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA )
1 Jun 2019
The value of surgery in ovarian cancer
Prof Christina Fotopoulou - Queen Charlotte's and Chelsea Hospital, London, UK
The value of surgery in ovarian cancer ( Prof Christina Fotopoulou - Queen Charlotte's and Chelsea Hospital, London, UK )
24 May 2019
Latest in ovarian cancer treatment
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
Latest in ovarian cancer treatment ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )
24 May 2019
Novel adoptive cell therapies for acute lymphoblastic leukaemia
Prof Rupert Handgretinger, Director and Chair, Children’s University Hospital...
Novel adoptive cell therapies for acute lymphoblastic leukaemia ( Prof Rupert Handgretinger, Director and Chair, Children’s University Hospital and Department of Haematology/Oncology, Tübingen, Germany )
24 May 2019
Issues in allogeneic HSCT: Therapeutic options for post-transplant relapse
Prof David Marks - University Hospital Bristol, Bristol, UK
Issues in allogeneic HSCT: Therapeutic options for post-transplant relapse ( Prof David Marks - University Hospital Bristol, Bristol, UK )
24 May 2019
CNS involvement and prophylaxis in acute lymphoblastic leukaemia
Dr Mark Litzow - Mayo Clinic, Rochester, USA
CNS involvement and prophylaxis in acute lymphoblastic leukaemia ( Dr Mark Litzow - Mayo Clinic, Rochester, USA )
24 May 2019
Indications for allogeneic haematopoietic stem cell transplantation in adult...
Dr Mark Litzow - Mayo Clinic, Rochester, USA
Indications for allogeneic haematopoietic stem cell transplantation in adult acute lymphoblastic leukaemia ( Dr Mark Litzow - Mayo Clinic, Rochester, USA )
24 May 2019
Updates on bispecific T cell engagers (BiTEs) for the treatment of acute...
Prof Max Topp - University of Würzburg, Würzburg, Germany
Updates on bispecific T cell engagers (BiTEs) for the treatment of acute lymphoblastic leukaemia ( Prof Max Topp - University of Würzburg, Würzburg, Germany )
24 May 2019
MRD management in adults with acute lymphoblastic leukaemia
Dr Renato Bassan - Ospedale dell'Angelo & Ospedale SS, Venice, Italy
MRD management in adults with acute lymphoblastic leukaemia ( Dr Renato Bassan - Ospedale dell'Angelo & Ospedale SS, Venice, Italy )
24 May 2019
Using CAR T cells for the treatment of acute lymphoblastic leukaemia
Prof Claudia Rossig - Universität Münster, Münster, Germany
Using CAR T cells for the treatment of acute lymphoblastic leukaemia ( Prof Claudia Rossig - Universität Münster, Münster, Germany )
24 May 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation